vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and V2X, Inc. (VVX). Click either name above to swap in a different company.

V2X, Inc. is the larger business by last-quarter revenue ($1.2B vs $617.0M, roughly 2.0× CLARIVATE PLC). V2X, Inc. runs the higher net margin — 1.9% vs 0.5%, a 1.4% gap on every dollar of revenue. On growth, V2X, Inc. posted the faster year-over-year revenue change (5.3% vs -6.9%). V2X, Inc. produced more free cash flow last quarter ($207.2M vs $89.2M). Over the past eight quarters, V2X, Inc.'s revenue compounded faster (9.8% CAGR vs -0.3%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

V2X, Inc. is a leading provider of integrated technology solutions, mission support services, and critical infrastructure engineering primarily serving U.S. federal government clients including the Department of Defense and civilian agencies, as well as select commercial customers. It delivers end-to-end capabilities for national security, public safety, and operational resilience across its core operating segments.

CLVT vs VVX — Head-to-Head

Bigger by revenue
VVX
VVX
2.0× larger
VVX
$1.2B
$617.0M
CLVT
Growing faster (revenue YoY)
VVX
VVX
+12.2% gap
VVX
5.3%
-6.9%
CLVT
Higher net margin
VVX
VVX
1.4% more per $
VVX
1.9%
0.5%
CLVT
More free cash flow
VVX
VVX
$118.0M more FCF
VVX
$207.2M
$89.2M
CLVT
Faster 2-yr revenue CAGR
VVX
VVX
Annualised
VVX
9.8%
-0.3%
CLVT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLVT
CLVT
VVX
VVX
Revenue
$617.0M
$1.2B
Net Profit
$3.1M
$22.8M
Gross Margin
66.8%
8.6%
Operating Margin
6.7%
4.2%
Net Margin
0.5%
1.9%
Revenue YoY
-6.9%
5.3%
Net Profit YoY
101.6%
-9.0%
EPS (diluted)
$0.00
$0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
VVX
VVX
Q4 25
$617.0M
$1.2B
Q3 25
$623.1M
$1.2B
Q2 25
$621.4M
$1.1B
Q1 25
$593.7M
$1.0B
Q4 24
$663.0M
$1.2B
Q3 24
$622.2M
$1.1B
Q2 24
$650.3M
$1.1B
Q1 24
$621.2M
$1.0B
Net Profit
CLVT
CLVT
VVX
VVX
Q4 25
$3.1M
$22.8M
Q3 25
$-28.3M
$24.6M
Q2 25
$-72.0M
$22.4M
Q1 25
$-103.9M
$8.1M
Q4 24
$-191.8M
$25.0M
Q3 24
$-65.6M
$15.1M
Q2 24
$-304.3M
$-6.5M
Q1 24
$-75.0M
$1.1M
Gross Margin
CLVT
CLVT
VVX
VVX
Q4 25
66.8%
8.6%
Q3 25
65.0%
8.1%
Q2 25
67.2%
8.9%
Q1 25
65.1%
7.7%
Q4 24
65.7%
9.3%
Q3 24
66.2%
8.5%
Q2 24
67.2%
6.9%
Q1 24
64.9%
7.0%
Operating Margin
CLVT
CLVT
VVX
VVX
Q4 25
6.7%
4.2%
Q3 25
7.1%
4.8%
Q2 25
1.1%
4.9%
Q1 25
-3.5%
3.4%
Q4 24
-9.4%
4.5%
Q3 24
3.5%
4.6%
Q2 24
-36.9%
2.6%
Q1 24
0.8%
3.0%
Net Margin
CLVT
CLVT
VVX
VVX
Q4 25
0.5%
1.9%
Q3 25
-4.5%
2.1%
Q2 25
-11.6%
2.1%
Q1 25
-17.5%
0.8%
Q4 24
-28.9%
2.2%
Q3 24
-10.5%
1.4%
Q2 24
-46.8%
-0.6%
Q1 24
-12.1%
0.1%
EPS (diluted)
CLVT
CLVT
VVX
VVX
Q4 25
$0.00
$0.73
Q3 25
$-0.04
$0.77
Q2 25
$-0.11
$0.70
Q1 25
$-0.15
$0.25
Q4 24
$-0.27
$0.78
Q3 24
$-0.09
$0.47
Q2 24
$-0.46
$-0.21
Q1 24
$-0.14
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
VVX
VVX
Cash + ST InvestmentsLiquidity on hand
$329.2M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$4.8B
$1.1B
Total Assets
$11.1B
$3.3B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
VVX
VVX
Q4 25
$329.2M
Q3 25
$318.7M
Q2 25
$362.6M
Q1 25
$354.0M
Q4 24
$295.2M
Q3 24
$388.5M
Q2 24
$376.4M
Q1 24
$361.8M
Total Debt
CLVT
CLVT
VVX
VVX
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Q2 24
$4.6B
Q1 24
$4.6B
Stockholders' Equity
CLVT
CLVT
VVX
VVX
Q4 25
$4.8B
$1.1B
Q3 25
$4.9B
$1.1B
Q2 25
$5.0B
$1.1B
Q1 25
$5.0B
$1.0B
Q4 24
$5.1B
$1.0B
Q3 24
$5.5B
$1.0B
Q2 24
$5.6B
$992.0M
Q1 24
$5.9B
$993.7M
Total Assets
CLVT
CLVT
VVX
VVX
Q4 25
$11.1B
$3.3B
Q3 25
$11.2B
$3.2B
Q2 25
$11.4B
$3.1B
Q1 25
$11.5B
$3.1B
Q4 24
$11.5B
$3.2B
Q3 24
$12.0B
$3.1B
Q2 24
$12.1B
$3.2B
Q1 24
$12.5B
$3.1B
Debt / Equity
CLVT
CLVT
VVX
VVX
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
Q2 24
0.83×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
VVX
VVX
Operating Cash FlowLast quarter
$159.9M
$209.5M
Free Cash FlowOCF − Capex
$89.2M
$207.2M
FCF MarginFCF / Revenue
14.5%
17.0%
Capex IntensityCapex / Revenue
11.5%
0.2%
Cash ConversionOCF / Net Profit
51.58×
9.20×
TTM Free Cash FlowTrailing 4 quarters
$365.3M
$170.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
VVX
VVX
Q4 25
$159.9M
$209.5M
Q3 25
$181.1M
$39.4M
Q2 25
$116.3M
$28.5M
Q1 25
$171.2M
$-95.5M
Q4 24
$141.3M
$223.1M
Q3 24
$202.9M
$62.7M
Q2 24
$126.2M
$25.7M
Q1 24
$176.2M
$-57.2M
Free Cash Flow
CLVT
CLVT
VVX
VVX
Q4 25
$89.2M
$207.2M
Q3 25
$115.5M
$35.0M
Q2 25
$50.3M
$26.1M
Q1 25
$110.3M
$-98.2M
Q4 24
$59.1M
$222.0M
Q3 24
$126.3M
$60.5M
Q2 24
$60.3M
$24.9M
Q1 24
$111.8M
$-65.0M
FCF Margin
CLVT
CLVT
VVX
VVX
Q4 25
14.5%
17.0%
Q3 25
18.5%
3.0%
Q2 25
8.1%
2.4%
Q1 25
18.6%
-9.7%
Q4 24
8.9%
19.2%
Q3 24
20.3%
5.6%
Q2 24
9.3%
2.3%
Q1 24
18.0%
-6.4%
Capex Intensity
CLVT
CLVT
VVX
VVX
Q4 25
11.5%
0.2%
Q3 25
10.5%
0.4%
Q2 25
10.6%
0.2%
Q1 25
10.3%
0.3%
Q4 24
12.4%
0.1%
Q3 24
12.3%
0.2%
Q2 24
10.1%
0.1%
Q1 24
10.4%
0.8%
Cash Conversion
CLVT
CLVT
VVX
VVX
Q4 25
51.58×
9.20×
Q3 25
1.60×
Q2 25
1.27×
Q1 25
-11.78×
Q4 24
8.91×
Q3 24
4.16×
Q2 24
Q1 24
-50.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Academia Government Group$312.3M51%
Re Occurring Revenues$114.1M18%
Life Sciences And Healthcare Group$98.3M16%
Transactional Revenues$97.1M16%

VVX
VVX

Army$480.4M39%
Navy$388.9M32%
Air Force$196.1M16%
Other Customers$153.3M13%

Related Comparisons